It targets the juxtamembrane region of HER2, exerting its anticancer activity through several suggested mechanisms downregulation of the HER2 receptor, inhibition of cell cycle proliferation, activation of antibodydependant cellular toxicity, and finally, inhibition of vascular endothelial growth factor VEGF <a href=https://fastpriligy.top/>buy priligy</a>
发表于